SEOUL (Reuters) – South Korea has approved Pfizer’s COVID-19 vaccine for use with children aged 5-11, the country’s food and drug ministry said on Wednesday.
Children should get one-third of the regular dose, twice with a three week interval, the ministry said in a statement. Children with significantly declined immunity can get a booster four weeks later.
(Reporting by Josh Smith)
